These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 34202812)

  • 1. Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies.
    Irrera N; Bitto A; Sant'Antonio E; Lauro R; Musolino C; Allegra A
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34202812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?
    Giaginis C; Lakiotaki E; Korkolopoulou P; Konstantopoulos K; Patsouris E; Theocharis S
    Curr Med Chem; 2016; 23(22):2350-62. PubMed ID: 27237820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rise of apoptosis: targeting apoptosis in hematologic malignancies.
    Valentin R; Grabow S; Davids MS
    Blood; 2018 Sep; 132(12):1248-1264. PubMed ID: 30012635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future Aspects for Cannabinoids in Breast Cancer Therapy.
    Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving role of the endocannabinoid system in gynaecological cancer.
    Ayakannu T; Taylor AH; Willets JM; Konje JC
    Hum Reprod Update; 2015; 21(4):517-35. PubMed ID: 25958409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting immune checkpoints in hematological malignancies.
    Salik B; Smyth MJ; Nakamura K
    J Hematol Oncol; 2020 Aug; 13(1):111. PubMed ID: 32787882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMTP1, a novel tumor-homing peptide, specifically targets hematological malignancies and their metastases.
    Xiao M; Hong Z; Sun L; Wu Y; Zhang N; Liu Y; Luo D; Zhou J; Li C
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):608. PubMed ID: 22038348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiogenesis and hematological malignancies].
    Iversen PO
    Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3198-200. PubMed ID: 14714007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interaction of the cannabinoid and death receptor systems - a potential target for future cancer therapies?
    Keresztes A; Streicher JM
    FEBS Lett; 2017 Oct; 591(20):3235-3251. PubMed ID: 28948607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
    Karanian DA; Bahr BA
    Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
    Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
    Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
    Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
    Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
    De Luca MA; Fattore L
    Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
    Gotfried J; Naftali T; Schey R
    Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.